BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9570577)

  • 1. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation.
    Scholz C; Patton KT; Anderson DE; Freeman GJ; Hafler DA
    J Immunol; 1998 Feb; 160(3):1532-8. PubMed ID: 9570577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis.
    Börnsen L; Christensen JR; Ratzer R; Oturai AB; Sørensen PS; Søndergaard HB; Sellebjerg F
    PLoS One; 2012; 7(11):e47578. PubMed ID: 23226199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct ex vivo analysis of activated, Fas-sensitive autoreactive T cells in human autoimmune disease.
    Bieganowska KD; Ausubel LJ; Modabber Y; Slovik E; Messersmith W; Hafler DA
    J Exp Med; 1997 May; 185(9):1585-94. PubMed ID: 9151896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.
    Hemmer B; Fleckenstein BT; Vergelli M; Jung G; McFarland H; Martin R; Wiesmüller KH
    J Exp Med; 1997 May; 185(9):1651-9. PubMed ID: 9151902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis.
    Calabrò M; Lui M; Mazzon E; D'Angiolini S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational Approaches Targeting Ceramide Generation From Sphingomyelin in T Cells to Modulate Immunity in Humans.
    Hollmann C; Wiese T; Dennstädt F; Fink J; Schneider-Schaulies J; Beyersdorf N
    Front Immunol; 2019; 10():2363. PubMed ID: 31681273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.
    Correale J; Marrodan M; Ysrraelit MC
    Biomedicines; 2019 Feb; 7(1):. PubMed ID: 30791637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes T
    Aqel SI; Kraus EE; Jena N; Kumari V; Granitto MC; Mao L; Farinas MF; Zhao EY; Perottino G; Pei W; Lovett-Racke AE; Racke MK; Fuchs JR; Li C; Yang Y
    Clin Exp Immunol; 2019 May; 196(2):215-225. PubMed ID: 30615197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for Blimp-1 in autoreactive CD4 T cells during priming and effector phase of autoimmune encephalomyelitis.
    Aqel SI; Granitto MC; Nuro-Gyina PK; Pei W; Liu Y; Lovett-Racke AE; Racke MK; Yang Y
    J Neuroimmunol; 2018 Dec; 325():20-28. PubMed ID: 30366205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphite oxidase (SO) - a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis.
    Preuß BE; Berg CP; Werner C; Plankenhorn S; Malek NP; Klein R
    BMC Gastroenterol; 2018 May; 18(1):58. PubMed ID: 29720090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal hepatic encephalopathy is associated with expansion and activation of CD
    Mangas-Losada A; García-García R; Urios A; Escudero-García D; Tosca J; Giner-Durán R; Serra MA; Montoliu C; Felipo V
    Sci Rep; 2017 Jul; 7(1):6683. PubMed ID: 28751644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System.
    Pilli D; Zou A; Tea F; Dale RC; Brilot F
    Front Immunol; 2017; 8():652. PubMed ID: 28638382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism.
    Işik N; Yildiz Manukyan N; Aydin Cantürk İ; Candan F; Ünsal Çakmak A; Saru Han Direskeneli G
    Noro Psikiyatr Ars; 2014 Mar; 51(1):69-73. PubMed ID: 28360598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Sclerosis and Obesity: Possible Roles of Adipokines.
    Guerrero-García JJ; Carrera-Quintanar L; López-Roa RI; Márquez-Aguirre AL; Rojas-Mayorquín AE; Ortuño-Sahagún D
    Mediators Inflamm; 2016; 2016():4036232. PubMed ID: 27721574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
    Zhang Q; Vignali DA
    Immunity; 2016 May; 44(5):1034-51. PubMed ID: 27192568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.
    Riedhammer C; Weissert R
    Front Immunol; 2015; 6():322. PubMed ID: 26136751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of T Follicular Helper cells in Multiple Sclerosis.
    Schmitt N
    J Nat Sci; 2015; 1(7):e139. PubMed ID: 26082945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy.
    Rasouli J; Ciric B; Imitola J; Gonnella P; Hwang D; Mahajan K; Mari ER; Safavi F; Leist TP; Zhang GX; Rostami A
    J Immunol; 2015 Jun; 194(11):5085-93. PubMed ID: 25917097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.
    Fujiwara M; Anstadt EJ; Khanna KM; Clark RB
    Clin Immunol; 2015 May; 158(1):103-13. PubMed ID: 25829233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics.
    Pieper J; Johansson S; Snir O; Linton L; Rieck M; Buckner JH; Winqvist O; van Vollenhoven R; Malmström V
    Scand J Immunol; 2014 Feb; 79(2):149-55. PubMed ID: 24313359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.